Healthcare provider profile · identity verified

Martha E Ziegler, MD

Allopathic & Osteopathic Physicians|Family Medicine · SOUTH PITTSBURG, TN · NPI 1811940992

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Martha E Ziegler, MD received $154.20 in general payments during 2025 across 8 reported records.

Lilly USA, LLC accounted for 75.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro, Ozempic.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 66 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Trulicity by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 204 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$154.20

8 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$116.70	75.7%	6	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$37.50	24.3%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$154.20	8

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$116.70	6	2025
Source payment records 2025-03-18 · Lilly USA, LLC · $17.42 · Open Payments source 2025-04-22 · Lilly USA, LLC · $18.04 · Open Payments source 2025-07-22 · Lilly USA, LLC · $17.65 · Open Payments source 2025-08-19 · Lilly USA, LLC · $20.20 · Open Payments source 2025-09-16 · Lilly USA, LLC · $18.49 · Open Payments source 2025-10-21 · Lilly USA, LLC · $24.90 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$37.50	2	2025
Source payment records 2025-04-08 · Novo Nordisk Inc · $15.26 · Open Payments source 2025-06-05 · Novo Nordisk Inc · $22.24 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$22.24	1	2025
Source payment records 2025-06-05 · Novo Nordisk Inc · $22.24 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	66	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	204	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	58	11
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	66	13
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	64	13
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	204	51

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1085	304
Amlodipine Besylate	Amlodipine Besylate	832	239
Levothyroxine Sodium	Levothyroxine Sodium	746	186
Omeprazole	Omeprazole	739	216
Lisinopril	Lisinopril	660	189
Losartan Potassium	Losartan Potassium	646	176
Albuterol Sulfate Hfa	Albuterol Sulfate	588	140
Rosuvastatin Calcium	Rosuvastatin Calcium	517	156
Gabapentin	Gabapentin	502	104
Trazodone Hcl	Trazodone Hcl	462	115
Metformin Hcl	Metformin Hcl	415	113
Hydrochlorothiazide	Hydrochlorothiazide	408	113
Potassium Chloride	Potassium Chloride	402	118
Metoprolol Tartrate	Metoprolol Tartrate	370	101
Pantoprazole Sodium	Pantoprazole Sodium	369	104
Prednisone	Prednisone	355	207
Furosemide	Furosemide	331	117
Tamsulosin Hcl	Tamsulosin Hcl	320	88
Sertraline Hcl	Sertraline Hcl	293	76
Meloxicam	Meloxicam	275	84
Simvastatin	Simvastatin	268	79
Buspirone Hcl	Buspirone Hcl	263	65
Famotidine	Famotidine	263	74
Metoprolol Succinate	Metoprolol Succinate	257	77
Carvedilol	Carvedilol	252	78
Amoxicillin	Amoxicillin	243	190
Fenofibrate	Fenofibrate Nanocrystallized	241	71
Eliquis	Apixaban	237	47
Glipizide	Glipizide	235	64
Duloxetine Hcl	Duloxetine Hcl	212	56
Ozempic	Semaglutide	204	51
Montelukast Sodium	Montelukast Sodium	200	54
Ondansetron Odt	Ondansetron	200	72
Alendronate Sodium	Alendronate Sodium	190	46
Azithromycin	Azithromycin	180	124
Januvia	Sitagliptin Phosphate	179	33
Clopidogrel	Clopidogrel Bisulfate	175	57
Metformin Hcl Er	Metformin Hcl	171	46
Pregabalin	Pregabalin	164	37
Estradiol	Estradiol	161	41
Escitalopram Oxalate	Escitalopram Oxalate	160	39
Alprazolam	Alprazolam	159	23
Tizanidine Hcl	Tizanidine Hcl	159	42
Zolpidem Tartrate	Zolpidem Tartrate	153	28
Ezetimibe	Ezetimibe	148	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	147	41
Cefuroxime	Cefuroxime Axetil	145	93
Fluoxetine Hcl	Fluoxetine Hcl	145	36
Spironolactone	Spironolactone	145	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	143	28
Pravastatin Sodium	Pravastatin Sodium	139	41
Promethazine Hcl	Promethazine Hcl	139	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	135	35
Tramadol Hcl	Tramadol Hcl	134	39
Methylprednisolone	Methylprednisolone	131	92
Citalopram Hbr	Citalopram Hydrobromide	130	42
Ropinirole Hcl	Ropinirole Hcl	129	35
Fluticasone Propionate	Fluticasone Propionate	128	47
Hydralazine Hcl	Hydralazine Hcl	126	24
Methocarbamol	Methocarbamol	126	49
Warfarin Sodium	Warfarin Sodium	126	21
Mirtazapine	Mirtazapine	122	39
Esomeprazole Magnesium	Esomeprazole Magnesium	118	35
Glimepiride	Glimepiride	113	28
Farxiga	Dapagliflozin Propanediol	111	27
Fluconazole	Fluconazole	111	67
Diazepam	Diazepam	110	20
Allopurinol	Allopurinol	107	33
Benazepril Hcl	Benazepril Hcl	104	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	104	24
Meclizine Hcl	Meclizine Hcl	99	32
Baclofen	Baclofen	97	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	26
Valsartan	Valsartan	97	24
Doxycycline Hyclate	Doxycycline Hyclate	92	62
Dicyclomine Hcl	Dicyclomine Hcl	90	20
Donepezil Hcl	Donepezil Hcl	88	24
Clonazepam	Clonazepam	85	11
Ibuprofen	Ibuprofen	82	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	80	69
Synthroid	Levothyroxine Sodium	80	24
Clonidine Hcl	Clonidine Hcl	79	23
Ondansetron Hcl	Ondansetron Hcl	79	46
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	73	23
Mupirocin	Mupirocin	73	48
Celecoxib	Celecoxib	70	21
Cephalexin	Cephalexin	68	58
Glipizide Er	Glipizide	68	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	68	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	19
Mounjaro	Tirzepatide	66	13
Venlafaxine Hcl Er	Venlafaxine Hcl	65	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	64	18
Trulicity	Dulaglutide	64	13
Valacyclovir	Valacyclovir Hcl	64	28
Atenolol	Atenolol	63	21
Paroxetine Hcl	Paroxetine Hcl	61	21
Myrbetriq	Mirabegron	60	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	60	46
Testosterone Cypionate	Testosterone Cypionate	59	12
Jardiance	Empagliflozin	58	11
Tresiba Flextouch U-100	Insulin Degludec	58	14
Nebivolol Hcl	Nebivolol Hcl	57	12
Gemfibrozil	Gemfibrozil	55	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	13
Propranolol Hcl	Propranolol Hcl	52	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	50	suppressed
Memantine Hcl	Memantine Hcl	49	11
Quetiapine Fumarate	Quetiapine Fumarate	49	11
Lorazepam	Lorazepam	47	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	12
Amitriptyline Hcl	Amitriptyline Hcl	46	14
Levetiracetam	Levetiracetam	45	suppressed
Xarelto	Rivaroxaban	44	suppressed
Lovastatin	Lovastatin	43	14
Diclofenac Sodium	Diclofenac Sodium	42	16
Levemir Flexpen	Insulin Detemir	42	15
Finasteride	Finasteride	41	11
Nystatin	Nystatin	41	27
Bupropion Xl	Bupropion Hcl	39	13
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Linzess	Linaclotide	39	11
Novolog Flexpen	Insulin Aspart	39	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Acyclovir	Acyclovir	38	11
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	12
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Bupropion Hcl Sr	Bupropion Hcl	37	suppressed
Aripiprazole	Aripiprazole	36	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Bumetanide	Bumetanide	35	suppressed
Naproxen	Naproxen	34	suppressed
Sucralfate	Sucralfate	34	19
Benzonatate	Benzonatate	33	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	24
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Tresiba Flextouch U-200	Insulin Degludec	33	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Nitroglycerin	Nitroglycerin	32	13
Paxlovid	Nirmatrelvir/Ritonavir	32	32
Irbesartan	Irbesartan	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	suppressed
Breyna	Budesonide/Formoterol Fumarate	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Bupropion Hcl	Bupropion Hcl	27	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Levofloxacin	Levofloxacin	23	15
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Topiramate	Topiramate	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Digoxin	Digoxin	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	12
Fenofibrate	Fenofibrate,micronized	22	suppressed
Torsemide	Torsemide	22	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	11
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Colchicine	Colchicine	21	11
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Novolog	Insulin Aspart	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	19	suppressed
Hydrocortisone	Hydrocortisone	19	14
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	12
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	17	15
Oseltamivir Phosphate	Oseltamivir Phosphate	17	16
Clindamycin Hcl	Clindamycin Hcl	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Lagevrio (Eua)	Molnupiravir	16	15
Oxcarbazepine	Oxcarbazepine	16	suppressed
Temazepam	Temazepam	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Glyburide	Glyburide	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Nurtec Odt	Rimegepant Sulfate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Emgality Pen	Galcanezumab-Gnlm	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$154.20 · 8 records	Lilly USA, LLC	MOUNJARO, Ozempic, Rybelsus	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error